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Abstract
Background: Arylamine N-acetyltransferase 2 (NAT2) is an important catalytic enzyme that metabolizes the carcinogenic
arylamines, hydrazine drugs and chemicals. This enzyme is highly polymorphic in different human populations. Several
polymorphisms of NAT2, including the single amino acid substitutions R64Q, I114T, D122N, L137F, Q145P, R197Q, and
G286E, are classified as slow acetylators, whereas the wild-type NAT2 is classified as a fast acetylator. The slow acetylators
are often associated with drug toxicity and efficacy as well as cancer susceptibility. The biological functions of these 7
mutations have previously been characterized, but the structural basis behind the reduced catalytic activity and reduced
protein level is not clear.
Methodology/Principal Findings: We performed multiple molecular dynamics simulations of these mutants as well as NAT2
to investigate the structural and dynamical effects throughout the protein structure, specifically the catalytic triad, cofactor
binding site, and the substrate binding pocket. None of these mutations induced unfolding; instead, their effects were
confined to the inter-domain, domain 3 and 17-residue insert region, where the flexibility was significantly reduced relative
to the wild-type. Structural effects of these mutations propagate through space and cause a change in catalytic triad
conformation, cofactor binding site, substrate binding pocket size/shape and electrostatic potential.
Conclusions/Significance: Our results showed that the dynamical properties of all the mutant structures, especially in inter-
domain, domain 3 and 17-residue insert region were affected in the same manner. Similarly, the electrostatic potential of all
the mutants were altered and also the functionally important regions such as catalytic triad, cofactor binding site, and
substrate binding pocket adopted different orientation and/or conformation relative to the wild-type that may affect the
functions of the mutants. Overall, our study may provide the structural basis for reduced catalytic activity and protein level,
as was experimentally observed for these polymorphisms.
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Introduction
The enzymes arylamine N-acetyltransferases (NATs, EC
2.3.1.5) catalyze the transfer of an acetyl group from acetyl CoA
to arylamine, hydrazines and their N-hydroxylated metabolites,
thus playing an important role in detoxification and potential
metabolic activation of numerous xenobiotics [1]. NATs have
been identified and characterized in many eukaryotes and
prokaryotes [2]. In humans, NAT exists as 2 isozymes: NAT1
and NAT2, both of which are 290 amino acids long and share
81% sequence identity but differ in their tissue distribution and
substrate specificity [3]. Both NAT1 and NAT2 are highly
polymorphic and catalyze the metabolism of many aromatic
amines and hydrazine drugs. NAT2 mainly catalyzes the N-
actetylation of arylamines and the O-acetylation of N-hydroxylated
metabolites of arylamines and heterocyclic amines [4]. Genetic
variability in NAT2 is responsible for the variation in the
inactivation of the anti-tubercular drug isoniazid [5]. NAT2
acetylation polymorphism modifies the toxicity of a number of
aromatic and hydrazine drugs in humans [6].
To date, 34 single nucleotide polymorphisms (SNPs) have been
identified in the human NAT2 protein coding region (http://louisville.
edu/medschool/pharmacology/consensus-human-arylamine-n-
acetyltransferase-gene-nomenclature/ nat_pdf_files/Human_NAT2_
alleles.pdf). According to the consensus of gene nomenclature of
human NAT2, 62 NAT2 alleles or haplotypes are characterized
by different combinations of these SNPs. Allelic variations in
NAT2 result in rapid, intermediate and slow acetylator pheno-
types [7,8,9]. The NAT2 allele (named NAT2*4), classified as a
wild-type (WT) allele with no SNPs, encodes an NAT2 protein
with high N-acetylation activity and confers a rapid acetylator
phenotype [10]. The SNPs in NAT2 such as G191A (R64Q),
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25801Figure 1. Sequence and secondary structure of N-acetyltransferase 2 (NAT2). The secondary structures are shown on the top of the
sequence and the residue numbers are shown on the bottom of the sequence. Each domain is colored separately (Domain 1-blue, Domain 2-red,
Inter Domain-green and Domain 3-yellow). The single nucleotide polymorphism (SNP) residues and the 17-residue insert region are highlighted in
cyan and orange respectively.
doi:10.1371/journal.pone.0025801.g001
Figure 2. Structure of N-acetyltransferase 2 (NAT2). (A) The overall fold of human NAT2 (PDB code: 2PFR) is shown in cartoon representation,
and each domain is colored as in Figure 1. The SNP residues are shown as space-filling representation in cyan. (B) The orientation of catalytic triad
residues C68, H107 and D122 is shown in stick representation, with carbon atoms in cyan, nitrogen in blue, oxygen in red and sulfur in yellow. (C)
Molecular surface in the vicinity of the substrate binding pocket of WT. The residues forming the pocket are in magenta.
doi:10.1371/journal.pone.0025801.g002
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(Q145P), G590A (R197Q), and G857A (G286E) are associated
with slow acetylator phenotypes. The amino acid substitution in
these mutants (MTs) results in a low metabolic rate of aromatic
and heterocyclic amines. The decreased catalytic activity of slow
acetylators leads the arylamines to be shunted toward the
hydroxylation pathway, which results in DNA reactive metabo-
lites [11]. Slow acetylators are associated with a high risk of
cigarette smoking-related breast cancer [11] and urinary bladder
cancer [12]. Some epidemiological studies have reported that
NAT2 polymorphisms modify the individual risk of various
cancers such as colon cancer [13], breast cancer [14,15,16] and
prostate cancer [17,18] with carcinogen exposure. Individuals
with slow acetylator phenotypes show a reduced amount of NAT2
protein expression in human liver [19,20]. Some of the slow
acetylator recombinant NAT2 proteins show reduced stability
[7,21,22] and others are targeted for proteosomal degradation
[23,24]. Certain individual SNPs such as G191A (R64Q), G364A
(D122N), A434C (Q145P) and G590A (R197Q) have reduced
catalytic activity, whereas G857A (G286E) differs in efficiency for
different substrates [10].
To understand the key structural changes induced by SNPs, the
homology modeled structure of NAT2 has been investigated in a
few studies [25,26,27]. These studies mainly used prokaryotic
NAT2 as a template to build a human NAT2 model. However,
the sequence similarity between the bacterial and human NAT2 is
low (,30%), and human NAT2 possesses an extra 17-residue
insertion region. These differences limit the use of the human
NAT2 model in understanding the effect of SNPs on the NAT2
structure.
Recently, the high resolution structure of human NAT2 was
determined [28] . Residues S1 to G83 in the N-terminus mainly
consisting of a-helices form a domain 1 (D1); residues F84-F192
mainly consisting of b-strands form a domain 2 (D2) followed by
inter-domain (ID) comprising residues T193-E229 and residues
G230 to I290 consisting of both a-helix and b-strands form a
domain 3 (Figure 1 and 2A). Similar to prokaryotic NATs, human
NAT2 also contains a cysteine protease-like catalytic core,
consisting of C68, H107 and D122, (Figure 2B), and the
arrangement of these catalytic residues is maintained by a
hydrogen-bond (H-bond) network and non-bond contacts. The
17-residue insertion is absent in the prokaryote NATs, and the
exact function of this insertion is not clear, although one study
suggests that it may contribute to the stability of the human NATs
[27]. Also, C-terminus of human NATs extends deep into the
active site, which is not observed in the prokaryote NATs. Previous
studies have proposed that NATs catalyze acetyl transfer by a
ping-pong bi-bi mechanism [29,30]. The formation of a thiolate-
imidazolium ion pair by C68 and H107 was found to be
catalytically important. The other catalytic triad residue D122
involved in ionic interaction with H107 is presumably important
for the activity and the structural integrity [31]. The substrate-
modeled crystal structure shows that the substrate fits well into
substrate binding pocket (SBP) [28], which is mainly formed by
residues C68, F93, V106, H107, D122, S125, F217 and S287
(Figure 2C). NAT proteins catalyze acetyl CoA (cofactor)
dependent acetylation of the substrates so that the binding of
cofactor is an important step in the NAT protein catalysis process.
However in the reported crystal structure, NAT2 binds with CoA
(Figure S1A), not acetyl CoA. Based on this crystal structure, Oda
et al [32] modeled the structure of NAT2 in complex with the
acetyl CoA (Figure S1B), and found that the hydrophobic core
comprising F37, W67, L69, F93, I95, V98, V106, F202, L209,
F217, and L288 around the SBP plays an important role in the
binding of acetyl CoA. The SNPs in this study distribute
throughout the structure and except for D122N, the remaining
are ,12 to 17 A ˚ away from the catalytic site.
Walraven et al [10] evaluated the SNP effect on the basis of the
NAT2 crystal structure, especially the H-bond interaction pattern
at the mutational site. However, the other changes, such as
conformational change at the catalytic triad, changes at the SBP,
dynamic motion of different regions and surface charge property
of the MTs, which are important for understanding the structural
basis related to the reduced catalytic activity and degradation of
the MTs, were not explained in detail. To completely understand
the effect of these polymorphisms at atomic resolution, the high-
resolution structures of the NAT2 variants are needed. However,
most of the NAT2 variants result in increased degradation or
aggregation, which makes structural studies difficult.
An atomic-level look at the protein dynamics through multiple
molecular dynamics simulations can help understand the effects of
these mutations on the protein structure, which allows for
investigating how one amino acid change can create a ripple
effect throughout the protein structure and eventually affect
cofactor binding, substrate binding, enzyme activity and protein
degradation. In this study, we generated the structures of 7 mutants
on the basis of the NAT2 crystal structure and investigated them
and the apo wild type (WT) by multiple molecular dynamics
simulation. These mutations changed the surface property and
induced structural changes that propagated through space to distort
the orientation of the catalytic residues, cofactor binding site, SBP
and especially the flexibility of domains ID and D3. Residues E174-
L181 of the 17-residue insert showed reduced flexibility in all 7
MTs. Our results provide possible explanations for the decreased
catalytic activity and degradation of the SNPs.
Materials and Methods
Starting structure
The bound coenzyme A and sulphate ion from the 1.92 A ˚
crystal NAT2 structure (PDB code: 2PFR) were removed, and the
resulting structure with 5000 steps (2000 steps of steepest descent
and 3000 steps of conjugated gradient) of energy minimization was
used as the starting structure of WT NAT2. The starting structures
for MTs were generated by substituting the amino acids for the
Table 1. General properties of wild-type (WT) and mutant
(MT) simulations
a.
Molecule Ca-RMSD
b (A ˚) Total SASA
c (A ˚ 2)
Total number of
hydrogen bonds
WT 2.060.8 13210.176147.89 26467
R64Q 2.160.6 12278.236126.62 24968
I114T 2.060.4 12676.216142.94 25866
D122N 2.160.4 12234.296138.44 24665
L137F 2.260.5 12175.646123.53 24968
Q145P 2.060.3 12745.606156.89 25269
R197Q 1.960.2 12126.916112.01 24865
G286E 1.960.4 12616.456160.51 24965
aProperties represent averages for 3 simulations over the last 10 ns of each
simulation.
bCa-RMSD - Root mean square deviation from the starting structure.
cSASA - Solvent accessible surface area.
doi:10.1371/journal.pone.0025801.t001
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performing 5000 steps of energy minimization.
Molecular dynamics simulation
Molecular dynamics simulations of WT and MTs were
performed using GROMACS [33] that adopts the GROMOS96
force-field parameters for energy minimization and molecular
dynamics simulations [34]. All the structures were solvated in a
periodic cubic box with walls extending at least 10 A ˚ from all
atoms. To obtain an electrically neutral system, the GENION
procedure from the GROMACS package was used to replace
water molecules with Na
+ and Cl
2 ions. The solvated structures
were energy minimized with the steepest descent method for 200
ps without using positional restraints. Then, 600 ps of molecular
dynamics with position restraints were performed to gently relax
the system, followed by dynamics simulations of the full system
without any positional restraints for 40,000 ps. Three independent
simulations of each protein were performed for a total of 960 ns of
simulation time.
All the simulations were performed in the NPT ensemble at a
constant temperature (310 K), and the pressure was maintained
by coupling to a reference pressure of 1 bar. The non-bonded
pair list was updated every 10 steps. The PME algorithm [35]
was applied to treat electrostatic interactions. All the bonds were
constrained with use of the LINCS algorithm [36], and the
SETTLE algorithm [37] was used to constrain the geometry of
the water molecules. A time step of 2 fs was used in all
calculations, and coordinates were saved at regular time intervals
of every 1 ps.
Analysis of molecular dynamics trajectories
Structural properties, such as root mean-square deviation
(RMSD) and root-mean square fluctuation (RMSF), were
calculated with the built-in functions of GROMACS. The solvent
accessible surface area (SASA) was calculated with the NACCESS
algorithm [38]. The hydrogen bond interactions were calculated
with the HBPLUS program [39]. All these analyses involved use of
the last 10-ns structures (Figure S2) of each simulation. The
electrostatic potential was calculated with the Discovery studio 2.5
and the protein interaction property similarity analysis server
(PIPSA) [40,41], which computes the electrostatic similarity and
dissimilarity between the WT and MTs. The last 10-ns averaged
structures from one simulation were used to calculate the
electrostatic potentials. The server uses the APBS software [42]
to calculate the electrostatic potentials, then the Hodgkin similarity
indices [43] were calculated for all pairs of proteins based on the
electrostatic similarity, then the similarity indices were converted
to electrostatic distances. Finally, the distance matrix is displayed
in a color-coded heat map form.
Results and Discussion
Effects of the mutations on NAT2 global structure
The overall structural parameters from the simulations are in
Table 1. To understand the overall structural stability throughout
the simulation, we calculated the RMSD of Ca atoms (Ca-RMSD)
from the appropriate starting structures for each simulation. For
the WT, the mean overall Ca-RMSD is 2.0 A ˚, whereas that for
MTs ranges from 1.9 to 2.2 A ˚. Relative to the WT, in MTs, the
amino acid substitutions do not increase the mean Ca-RMSD,
and similarly, all MT structures do not show an increase in total
SASA. Therefore, MT structures are stable and do not expand
appreciably during simulation. Interestingly, the mean number of
total H-bonds during the entire simulation differs slightly between
the WT and the MTs R64Q, D122N, L137F, R197Q and G286E.
Although the difference is not great, the reduced number of H-
bonds may affect the structural integrity. Further, the last ns (40
th)
structures from 3 independent simulations of each protein (Figure
S3) indicate that all proteins retain the NAT2 fold topology
throughout the simulations.
Effects of the mutations on NAT2 structural flexibility
To understand how these mutations affect the overall flexibility
of the protein, we calculated the RMSF of Ca atoms (Ca-RMSF),
which reflects the degree of main-chain fluctuations from the
mean structure over the simulation (Figure 3A-G). In the WT
simulations, Ca-RMSF values are almost on the same scale and
pattern as those of NAT2 crystallographic B-factors. Compared
with WT, all the MTs have specific regions with increased or
decreased fluctuations, specifically, the 17-residue insert region ID
and D3 showing a reduced flexibility in all MTs. Further, analysis
of the residues with .1A ˚ Ca-RMSF (Table 2) revealed that both
ID and D3 have lower percentage of residues, which indicates that
these 2 domains are more rigid. All MTs possessed a common
behavior in flexibility changes in the 17-residue insert region, ID
and D3.
Hydrogen bond changes at the mutational site
The amino acid substitutions in MTs are expected to result in
certain H-bond changes around the mutational site. We found no
apparent change in H-bond at the mutational site for I114T,
L137F and G286E, whereas some of the important H-bonds were
lost in R64Q, D122N, and Q145P (Table 3). For example, R64 of
the WT forms H-bonds with N41, H58 and I59 and a salt bridge
with E38, and these interactions were broken in R64Q. Because
Figure 3. Flexibility of WT and MT structures. The figure shows Ca-RMSF values (in A ˚) per residue for the WT (blue) compared with MTs (A)
R64Q, (B) I114T, (C) D122N, (D) L137F, (E) Q145P, (F) R197Q and (G) G286E (all in red). Crystallographic B-factors from the WT structure (PDB code:
2PFR) are colored in green. The Ca-RMSF values were calculated from the last 10-ns structures of each simulation. The alternate black and gray lines at
the bottom of the figure indicate the different domains.
doi:10.1371/journal.pone.0025801.g003
Table 2. Percentage of residues in each domain with .1A ˚
Ca-RMSF value calculated in WT and MT simulations.
Molecule D1
a D2
b ID
c D3
d
WT 12.8 18.4 28.5 35.0
R64Q 13.3 15.4 11.2 21.1
I114T 9.3 20.1 23.2 28.3
D122N 9.4 15.2 18.6 12.8
L137F 9.1 14.5 7.4 20.2
Q145P 14.3 19.4 12.3 21.4
R197Q 12.5 16.2 8.1 15.2
G286E 8.7 15.3 22.1 26.5
aD1 - Domain 1 (residues 1–83).
bD2 - Domain 2 (residues 84–192).
cID - Inter-domain (residues 193–229).
dD3 - Domain 3 (residues 230–290).
doi:10.1371/journal.pone.0025801.t002
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N41) and the salt bridge (R64/E38) are important for protein
function and/or stability [10]. E38 also forms an H-bond with
Q64 in R64Q but has a low percentage of occupancy, and the
interaction of the salt bridge is stronger than that of the H-bond, so
this H-bond may not be critical in function and stability of the
protein, as is the salt bridge in the WT. D122 of the WT forms an
H-bond with N72, G124, S125, Q130 and Y190 and an ionic
interaction with H107. In D122N, some of these H-bonds were
retained, but the important ionic interaction and the H-bonds with
residues S125 and Y190 were lost. Because residues N72, H107,
D122 and Y190 are highly conserved in mammalian and
prokaryotic NAT2, these residues and their interactions are
important for protein function. Although S125 is highly variable, it
is important for substrate selectivity [44]. Thus, disruption of the
H-bonds affects the conformation of the catalytic triad and
substrate binding site, which in turn affects the catalytic activity. In
Q145P, the substitution of Pro disrupts the H-bond interactions
with W132 and Q133, and loss of these H-bonds increases the
flexibility around the mutational site.
Therefore, the disruption of important H-bond interactions in
R64Q, D122N, and Q145P affects the flexibility around the
mutational site, which may affect the protein function.
Effects of the mutations on NAT2 local tertiary structure
Although mutations do not affect the global structure, the local
tertiary structures are significantly affected. To gain insight into
these changes, we analyzed the last 10-ns average structures for
each mutant. In R64Q, change in the fluctuation slightly alters the
orientation of secondary structures among a3, b2, b4 and b10,
and causes a large orientation change in a9 and a11. The
formation of new H-bonds by residues T214 and S215 in the a9–
a10 loop with T103 and S102 in the b3–b4 loop, respectively,
pulls the a9 towards the b2 and b4 (Figure 4A). I114T shows no
significant change in orientation of the secondary structure
(Figure 4B). In D122N, the flexibility is increased in the b3–b4
loop. Residues V106 and H107 in b4 lose the secondary structure
and hence are more flexible, which causes a significantly
conformational change of the catalytic triad residue H107
(Figure 4C). In L137F, F137 induces a steric clash with the
Table 3. Occupancy percentage of the hydrogen bond interactions at the mutation positions in the WT and MTs.
WT Hb
a Occu
b MTs Hb
a Occu
b
R64 9ARG(NH2):::64ARG(O) 18 R64Q 62ARG(NH2):::64GLN(OE1) 40
9ARG(NH1):::64ARG(O) 16 46GLN(NE2):::64GLN(OE1) 27
64ARG(NH2):::38GLU(OE2) 87 46GLN(NE2):::64GLN(NE2) 19
64ARG(NH2):::38GLU(OE1) 77 64GLN(NE2):::38GLU(OE2) 24
64ARG(NH2):::41ASN(OD1) 88
64ARG(N):::58HIS(O) 34
64ARG(NH2):::59ILE(O) 51
I114 114ILE(N):::117ARG(O) 72 I114T 114THR(N):::117ARG(O) 71
117ARG(N):::114ILE(O) 45 117ARG(N):::114THR(O) 14
D122 190TYR(OH):::122ASP(OD1) 80 D122N 122ASN(ND2):::108LEU(O) 24
190TYR(OH):::122ASP(OD2) 36 122ASN(ND2):::196TYR(OH) 76
130GLN(NE2)::: 122ASP(O) 70 130GLN(NE2):::122ASN(O) 57
125SER(OG)::: 122ASP(OD1) 97 124GLY(N):::122ASN(OD1) 47
125SER(N)::: 122ASP(OD1) 25 72ASN(ND2):::122ASN(OD1) 93
124GLY(N)::: 122ASP(OD1) 54
124GLY(N)::: 122ASP(OD2) 88
107HIS(NE2)::: 122ASP(OD2) 99
72ASN(ND2)::: 122ASP(OD2) 97
L137 137LEU(N):::118ASN(O) 90 L137F 137PHE(N):::118ASN(O) 35
139SER(OG):::137PHE(O) 17
Q145 145GLN(NE2):::133GLN(O) 82 Q145P 148CYS(N):::145PRO(O) 14
145GLN(NE2):::148CYS(O) 59
133GLN(N):::145GLN(OE1) 92
132TRP(N):::145GLN(OE1) 19
R197 197ARG(N):::88MET(O) 93 R197Q 197GLN(NE2):::105MET(O) 58
197GLN(NE2):::201ASP(OD1) 16
197GLN(N):::88MET(O) 88
197GLN(OE1):::90GLY(N) 35
G286 - G286E -
aHydrogen bonds.
bHydrogen bond occupancy percentage, only occupancies with $10 in each simulation are shown.
doi:10.1371/journal.pone.0025801.t003
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steric clash makes a slightly orientation change in these b-sheets.
Especially,themajor stericclashisobservedbetweenF137andF191
of b11. To accommodate F137, the b11 slightly alters its orientation,
which in turn affects the conformation of the following loop, a9a n d
a10. Compared with WT, the a9 moves towards the inside, which
affects the orientation of the a9-a10 loop and a10 (Figure 4D).
In Q145P, the increase in dynamics motion in D1 affects the
adjacent D3, especially in b13, b14 and a11. These regions move
outwards and expand the structure in the D3 (Figure 4E). This
observation is consistent with the total SASA of the Q145P (,12745
A ˚), which is slightly higher than that of the other MTs (Table 1).
Therefore, Q145Pslightlyexpands,especially inthe region of D3. In
R197Q, substitution of Gln for Arg affects the flexibility and
Figure 4. Mutational effects on NAT2 local tertiary structure. The local tertiary structure of the MTs (pink) is superimposed with the WT
structure (yellow). The average structures from last 10-ns of one simulation are shown here. The depicted structural changes were observed in all the
simulations for each protein. (A) In R64Q, two new H-bonds are formed, which are shown in stick representations. The first one is between T214
(cyan) and T103 (blue) and the other is between S215 (blue) and S102 (cyan), which pull the a9 towards the b2 and b4. (B) In I114T, most of secondary
structures conformation is very similar to the WT. (C) In D122N, residues V106 and H107 (blue, stick representation) loose its secondary structure and
become more flexible. The WT residues V106 and H107 are in yellow, stick representation. (D) In L137F, steric clash in b sheets affect the orientation of
a9 and a10. (E) In Q145P, the D3 (pink) expands slightly as compared with the WT (yellow). (F) In R197Q, one new H-bond is formed, which is shown
as cyan, stick representations. The residue S215 in the ID forms H-bond with D2 residue and S102, and pulls the a9 towards b2 and b4. (G) In G286E,
the two newly formed H-bonds S274-N41 (blue) and N278-E260 (cyan) significantly alter the conformation of the C-terminal tail relative to the WT.
doi:10.1371/journal.pone.0025801.g004
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observed in a9. Formation of a new H-bond by S215/S102 pulls the
a9 towards b2a n db4 (Figure 4F),which restricts the flexibilityofthe
a9 and the entire ID. In G286E, the conformation of the C-terminal
tail is altered significantly, primarily because of the formation of 2
new H-bonds (S274/N41 and N278/E260) (Figure 4G).
Effects of the mutations on NAT2 catalytic triad
conformation
To better understand how the mutations induce conformational
changes in the catalytic triad, we compared the conformation of
the catalytic triad of the WT and MTs (Figure 5). Changes in the
local tertiary structure and flexibility significantly affect the
conformation of the catalytic triad in all MTs except for I114T
and G286E; for both, the conformation and relative orientation of
the catalytic triad residues are similar to that of the WT. In
addition, the ionic interaction between the H107 and D122 is
preserved throughout the simulations for I114T and G286E,
whereas in all other MTs, this interaction is not seen.
Conformation of these residues is also severely altered, and the
increased distance between C68 and H107 may hinder the
formation of the thiolate-imidazolium ion pair.
Figure 5. Structural effects of mutations on NAT2 catalytic triad residues from molecular dynamics simulation. The averaged structure
from last 10-ns of the simulation of WT (orange) is superimposed with each MT (blue) averaged structure. Similar conformational changes were
observed in all simulations for each protein.
doi:10.1371/journal.pone.0025801.g005
Table 4. Solvent accessible surface area (SASA) of the
substrate binding pocket (SBP) and hydrophobic core around
the SBP in WT and MT simulations
a.
Molecule SASA Hydrophobic Core
b (A ˚)
2 SASA SBP
c (A ˚)
2
WT 310.76619.22 160.31622.35
R64Q 255.42619.43 124.13623.66
I114T 298.67618.54 156.66624.24
D122N 249.77619.41 122.55621.44
L137F 258.22619.66 126.71621.23
Q145P 248.71619.76 128.47621.45
R197Q 258.88621.11 124.57622.75
G286E 291.55619.76 152.46622.66
aSASA was calculated using structures from last 10-ns of each simulation.
bThe following residues were used to calculate the SASA of the hydrophobic core
aroundthe SBPsite:F37, W67,L69,F93, I95,V98, V106,F202, L209, F217 and L288.
cThe following residues were used to calculate the SASA of the SBP site: C68,
F93, V106, H107, D122, S125, F217 and S287.
doi:10.1371/journal.pone.0025801.t004
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binding pocket
In NAT2, the acetyl CoA molecule acts as a cofactor and plays
an important role in the acetylation of the substrates. The
proposed reaction mechanism contains 2 steps. In the first step, the
acetyl CoA–NAT2 complex is formed and then the acetyl group of
acetyl CoA is transferred to the catalytic triad residue C68.
Subsequently, the acetyl group from acetylated cysteine is
transferred to the substrate. Residues important for SBP and
acetyl CoA binding are nearby or overlapped, and those for CoA
binding form a hydrophobic core around SBP. Investigating the
SASA of the hydrophobic core and SBP revealed that changes in
Figure 6. Structural effects of the cofactor binding site and substrate binding pocket on MTs. (A) Molecular surface in the vicinity of the
cofactor binding site of the WT and MTs. The surface portions corresponding to the residues involved in forming the hydrophobic core around the
substrate binding pocket (F37, W67, L69, F93, I95, V98, V106, F202, L209, F217, and L288) are in magenta. (B) Molecular surface in the vicinity of the
substrate binding pocket of the WT and MTs. The surface portions corresponding to residues involved in forming the substrate binding pocket (C68,
F93, V106, H107, D122, S125, F217 and S287) are in green. A cavity is observed only in WT, I114T and G286E. Structures were taken from the snapshot
at 40
th ns from one simulation. Almost similar changes were observed in all the simulations of WT and each MT.
doi:10.1371/journal.pone.0025801.g006
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SBP size and/or shape (Table 4). The SASA values of all MTs,
except I114T and G286E, were greatly reduced, so the hydropho-
bic core and SBPin I114Tand G286E are close to those of the WT.
For the remaining MTs, the binding residues are more buried,
thereby altering the hydrophobic core and SBP. In addition, the
surface analysis of hydrophobic core (Figure 6A) and SBP
(Figure 6B) showed that for I114T and G286E and the WT, the
hydrophobic core and SBP region is retained, although the volume
of the pocket is not similar. For other MTs, surface analysis revealed
that the hydrophobic core and SBP are significantly distorted, and
no pocket is observed. The distortion of hydrophobic core and SBP
in these MTs may decrease the binding affinity for cofactor and
substrate. Because the mutants of NAT1 are unable to bind the
cofactor acetyl CoA, which results in protein degradation [45],
NAT2 MTs may also undergo a similar process.
Functional study revealed reduced protein level and enzymatic
activity for R64Q, D122N, L137F, Q145P and R197Q [24]. For
I114T and G286E, functional study revealed reduced protein
level, but the apparent kinetic parameters or protein stability did
not change in I114T [23], and the activity for certain substrates is
retained in G286E [7]. Our simulation data revealed that the MTs
R64Q, D122N, L137F, Q145P and R197Q affect the flexibility of
some domains and alter the orientation of some secondary
structures. These changes may be responsible for altering the
catalytic triad, hydrophobic core and SBP, which may prohibit the
binding of acetyl CoA and substrate, thereby significantly
decreasing the catalytic activity in these MTs. For I114T and
G286, most of the structural properties are close to that of the WT,
which is why both MTs retain the catalytic activity.
Effects of the mutations on NAT2 electrostatic potential
The electrostatic surface potentials are important for protein
structure and function. Mutations alter the protein surface
electrostatics that lead to diverse effects on protein structure,
including aggregation, folding and stability. Mutations in NAT2
often cause aggregation and/or reduced protein level because of
degradation. To understand the effects of these mutations on
protein surface charge property, we compared the electrostatic
potential between the WT and MTs. The electrostatic potential of
all MTs differed from that of the WT (Figure 7 and Figure S4).
The difference in surface charge may result in aggregation and/or
degradation on the MTs. Functional study of all MTs showed that
reduced protein level may be caused by degradation. For R64Q,
the change in surface charge property is the proposed mechanism
for the aggregation [7], which may also apply to the other MTs.
Probable ubiquitin substrate
Functional study of the MTs indicated that the protein level is
reduced, probably by the proteasomal degradation pathway [46].
NAT2 contains 15 Lys residues, all of which are solvent exposed,
and 9 are found in loops and flexible regions on the protein
surface. In our simulations, 2 Lys residues, K13 and K18, located
in the a1–a2 loop, and the other Lys residue, K184, located in the
a7–b11 loop, showed increased solvent exposure (Table S1). From
the differences in the WT and MT simulations, any one of these
Lys(s) may serve as targets for the ubiquitin modification in the
MT structure (Figure S5). However, further experiments such as
mutational analysis or ubiquitination assays are needed to identify
which Lys(s) is modified by ubiquitin.
Conclusions
NAT2 polymorphism is one of most common in humans, and
about half of all Caucasians possess the slow acetylator phenotype
of polymorphisms [9,47,48,49]. Because of the important role of
NAT2 in the metabolism of arylamine, hydrazine drugs and many
arylamine procarcinogens, understanding the structural basis of
acetylation polymorphism is of interest. To analyze the effects of
the SNPs on NAT2 structure and dynamics, we used multiple
molecular dynamics simulations of WT and 7 MT structures, with
40-ns for each simulation. Although the polymorphisms are
distributed in different regions, they have a cumulative effect on
the catalytic triad, cofactor binding site, SBP, surface property and
flexibility in different domains. The conformation of the catalytic
triad residues, as well as the cofactor binding site and SBP, is
altered severely in R64Q and D122N, which provides a possible
structural basis for the reduced catalytic activity in these MTs. In
comparison, conformation of the catalytic triad residues in the
MTs L137F, Q145P and R197Q is slightly perturbed but in
I114T and G286E is similar to that of the WT. For L137F, Q145P
and R197Q, the cofactor binding site and SBP are severely
distorted, which suggests a possible structural basis for the reduced
catalytic activity, whereas I114T and G286E show a slightly
distorted pocket, which suggests that these MTs can accommodate
the substrate. Interestingly, the electrostatic potential of all MTs
differs from that of the WT, which might affect their aggregation
and/or degradation.
Although previous study described the structural features and
functional effects of many NAT2 SNPs [10], the detailed analysis
of structural and dynamics changes, such as changes in the
catalytic triad, cofactor binding site and SBP, was not reported.
Here, we give a detailed analysis of how a single amino acid
substitution may cause major structural perturbations in functional
sites situated away from the mutational site, which provides a
Figure 7. Protein interaction property similarity analysis
(PIPSA) heat map of the WT and MT average structures. The
electrostatic distance is calculated and represented by the Hodgkin
similarity index [43]. The distances are color-coded from similar (red) to
dissimilar (magenta). The last 10-ns averaged structures from one
simulation of WT and MTs were used for the calculation. Similar
behaviors were observed in all the simulations of WT and MTs.
doi:10.1371/journal.pone.0025801.g007
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PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e25801better understanding of the role of NAT2 genetic polymorphism in
bioactivation and detoxification of arylamine and hydrazine drugs
and carcinogenesis. Further insight into the structure–function
relationships of the SNPs of NAT2 may be revealed by
investigation of other SNPs, such as R64W, E167K, K282T,
and also C68Y and G51V, reported recently from a Brazilian
population [50].
Supporting Information
Figure S1 Residues around the CoA and acetyl CoA. (A)
The hydrophobic residues around the CoA from the NAT2 crystal
structure (PDB:2PFR). (B) The hydrophobic residues around the
acetyl CoA from the modeled structure. This model was generated
by the Oda et al [32] procedure. The hydrophobic residues are
shown as green sticks and atoms of CoA and acetyl CoA are
colored as C gray, N blue, O red, and H gray, P orange, S yellow.
(TIF)
Figure S2 Overall Ca-RMSD of the wild-type (WT) and
mutant (MT) structures with respect to the starting
structures over 40-ns simulations. Three independent
simulations (black, red and green) of each protein were shown.
(TIF)
Figure S3 Mutations in NAT2 did not affect the overall
folding. Snapshots from the last ns (40
th) structures of three
independent simulations (blue, pink and green) of each protein
were superimposed.
(TIF)
Figure S4 Electrostatic potential on the surface of WT
and MTs. Electronegative and electropositive charges are
colored in red and blue, respectively.
(TIF)
Figure S5 Potential sites of NAT2 ubiqutination. NAT2
has 15 lysine residues distributed throughout the protein surface.
In our molecular dynamics simulations, 3 lysine residues (K13,
K18 and K184) located in unstructured regions of the protein
become more solvent-exposed in all the MTs. Any one of these
residues may be a substrate for ubiquitination. Cartoon diagram of
R64Q from last ns (40
th) structure is colored by domain (D1-
wheat, D2-pink, ID-grey and D3-bluewhite). The 3 lysine residues
are shown in stick representation.
(TIF)
Table S1 Solvent accessible surface area (SASA) of lysine
residues calculated from the last 10-ns average structure of WT
and MTs.
(DOC)
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